Couple of strengths I like about the business model already:
- Can keep adding products to it's suite at minimal cost, and already looks like the go to distributor in this field.
- Requires expertly trained sales staff to have knowledge of complex technologies.
- Relationship with CAJ gives it a gauranteed healthcare provider client.
Prospectus coming out in the next month. Looks like they'll have around 3m in cash, which in a way is a good level, as they won't be able to load up on expenses (CVT, DSX style) with basically no revenue. If they can keep losses to under 2m, their product sales will eventually grow past that in time.
Ultimately comes down to whether the 5 products they distribute are value adding for healthcare companies. Nobody really knows.
SFP Price at posting:
0.6¢ Sentiment: Hold Disclosure: Not Held
